← Mechanisms of action
Voltage-gated sodium channel
PROTEIN FAMILYRattus norvegicus
Linked proteins
- Sodium channel protein type 11 subunit alpha (Scn11a) ↗
- Sodium channel protein type 8 subunit alpha (Scn8a) ↗
- Sodium channel protein type 9 subunit alpha (Scn9a) ↗
- Sodium channel protein type 2 subunit alpha (Scn2a) ↗
- Sodium channel protein type 4 subunit alpha (Scn4a) ↗
- Sodium channel protein type 5 subunit alpha (Scn5a) ↗
- Sodium channel protein type 10 subunit alpha (Scn10a) ↗
- Sodium channel protein type 1 subunit alpha (Scn1a) ↗
- Sodium channel protein (Scn7a) ↗
- Sodium channel protein type 3 subunit alpha (Scn3a) ↗
- Sodium channel protein type 7 subunit alpha ↗
Drugs acting on this target (2)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| Oxetacaine | Inhibitor | experimental | Small molecule | Voltage-gated sodium channel inhibitor |
| pramocaine | Inhibitor | approved | Small molecule | Voltage-gated sodium channel inhibitor |